Biotecan Biology , A Leading Company in Precision Medicine
Introduction

At Shanghai Biotecan Pharmaceuticals Co. Ltd. our mission is to provide the best healthcare services through the most advanced technology. The company’s goal is to empower every medical professional and patient with specific knowledge to properly treat and prescribe patients symptoms and conditions through precision medicine. Biotecan uses strict quality management control system and strictly follows China’s GLP (Good Laboratory Practice of Drugs) standards. The company has International CAP Certification, and China’s Genetic Clinical Laboratory Certification (PCR).

Biotecan has an unparalleled team of experts from around the world in molecular diagnostics, medical big data, technology, engineering, and commercial development, making us a pioneer in precision medicine. Biotecan was founded in 2008, and currently owns 17 subsidiaries.


History
  • 2009

    Established Shanghai Pudong District’s first independent medical laboratory

  • 2011

    Established Shanghai Zhangjiang Translational Medical Research Center

  • 2013
    Founded Jining Jiu Genetic Modification Medical Research Corporation
    Approved as a Shanghai High-Technology Company
    Founded Biotecan Biomedicine Science and Technology Zhangjiakou Corporation
    Established Zhangjiang Translational Medical Center in Second Military Medical University Medicine
    Approved as Shanghai Medical Biomarker R&D and Industrialization of Public Service Platform
  • 2015
    National High Technology Research and Development - “863” Program (Biomedical Big Data Research and Development)
    Launched the National Post-Doctoral Program at Biotecan
    Established “Lung Cancer Precision Medicine Research and Development Center”
    Established Fudan-Zhangjiang joint “Precision Medicine Big Data Center”
  • 2017
    Establishment of first Biotecan Hi-tech Park——Dongyang Medical Union
    Full score in EQA of High-throughput Sequencing for Tumor
    Establishment of Shanghai Zhangjiang Medical Innovation Research Institute
  • 2019
    Shanghai Biotecan Medical laboratory successfully passed the NGSST EQA of the College of American Pathologists (CAP)
    Several times passed the 2019 EQA of the Clinic Center of Ministry of Health
    Core technologies entering the fast track of patent application for innovative technologies
    Shanghai Zhangjiang Medical Innovation Research Institute established The Intestinal Microecology Alliance with Shanghai 10th People's Hospital
    Launched the first Project Roadshow of Shanghai Zhangjiang Medical Innovation Research Institute (Zhangjiang Pharmaceutical Union)
    Honor of The Second Prize of Shanghai Intellectual Property Innovation Award for Core Technology Patent
  • 2008

    Biotecan was founded in 2008

  • 2010

    Granted “2010 Innovational Technology Project” Fund

  • 2012
    Cover of China’s Special Edition Issue - Established multicenter Clinical Research Center
    Co-sponsored Zhanjiang Forum on Translational Medicine - Launched the “10x1000 Project”
  • 2014
    Established Fudan-Zhangjiang Clinical Joint Molecular Research Center
    Co-Sponsored with Sinopharm Group Co. Ltd. and built the National Medical Big Data Platform
    Builds the National Independent Innovation Demonstration Zone Medical Big Data Public Service Platform
    National Development and Reform Commission constructs “National Science and Medical Molecular Translational Center”
  • 2016
    Construction of Zhangjiang National Innovation Innovation Demonstration Zone Precision Medicine Big Data Platform
    Establishment of Shanghai Precision Medicine Big Data Center
    Honor of Shanghai “Four Innovation” Economic Innovation Base
  • 2018
    Identified as "2017 Pudong New Area Enterprise Research and Development Institution"
    Honor of "Shanghai New Overseas Business Practice Base"
    Contract with Dalian High-tech Zone and Huawei to jointly build "Dalian High-tech Zone Life Science Big Data Platform"
    Settlement of Academician Yang Shengli Workstation in Biotecan
    Honor of “Zhangjiang Innovation TOP100” and “Quasi-Unicorn Innovative Enterprise”
  • 2008

    Biotecan was founded in 2008

  • 2009

    Established Shanghai Pudong District’s first independent medical laboratory.

  • 2010

    Granted “2010 Innovational Technology Project” Fund

  • 2011

    Established Shanghai Zhangjiang Translational Medical Research Center

  • 2012 Cover of China’s Special Edition Issue - Established the first multicenter Clinical Research Center   Co-sponsored Zhanjiang Forum on Translational Medicine - Launched the “10x1000 Project” 
  • 2013
    Founded Jining Jiu Genetic Modification Medical Research Corporation
    Approved as a Shanghai High-Technology Company
    Founded Biotecan Biomedicine Science and Technology Zhangjiakou Corporation
    Established Zhangjiang Translational Medical Center in Second Military Medical University Medicine
    Approved as Shanghai Medical Biomarker R&D and Industrialization of Public Service Platform
  • 2014
    Established Fudan-Zhangjiang Clinical Joint Molecular Research Center   Co-Sponsored with Sinopharm Group Co. Ltd. and built the National Medical Big Data Platform   Builds the National Independent Innovation Demonstration Zone Medical Big Data Public Service Platform   National Development and Reform Commission constructs “National Science and Medical Molecular Translational Center”
  • 2015
    National High Technology Research and Development - “863” Program (Biomedical Big Data Research and Development)
    Launched the National Post-Doctoral Program at Biotecan
    Established China’s first “Lung Cancer Precision Medicine Research and Development Center”
    Established Fudan-Zhangjiang joint “Precision Medicine Big Data Center”
  • 2016
    Listed on NEEQ   CCTV broadcasts interview with Biotecan   China Daily G20 Special Issue interview   Built the Medical Big Data Public Platform   Established over 90 Joint Molecular Medical Centers   Biotech relocates to Precision Medicine Industry Park   Established Shanghai Precision Medicine Big Data Center   Awarded Shanghai Economic Innovative Base
  • 2017
    Establishment of first Biotecan Hi-tech Park——Dongyang Medical Union
    Full score in EQA of High-throughput Sequencing for Tumor
    Establishment of Shanghai Zhangjiang Medical Innovation Research Institute
  • 2018
    Identified as "2017 Pudong New Area Enterprise Research and Development Institution"
    Honor of "Shanghai New Overseas Business Practice Base"
    Contract with Dalian High-tech Zone and Huawei to jointly build "Dalian High-tech Zone Life Science Big Data Platform"
    Settlement of Academician Yang Shengli Workstation in Biotecan
    Honor of “Zhangjiang Innovation TOP100” and “Quasi-Unicorn Innovative Enterprise”
  • 2019
    Shanghai Biotecan Medical laboratory successfully passed the NGSST EQA of the College of American Pathologists (CAP)
    Several times passed the 2019 EQA of the Clinic Center of Ministry of Health
    Core technologies entering the fast track of patent application for innovative technologies
    Shanghai Zhangjiang Medical Innovation Research Institute established The Intestinal Microecology Alliance with Shanghai 10th People's Hospital
    Launched the first Project Roadshow of Shanghai Zhangjiang Medical Innovation Research Institute (Zhangjiang Pharmaceutical Union)
    Honor of The Second Prize of Shanghai Intellectual Property Innovation Award for Core Technology Patent
Expert Team
  • Dr. HUA YU

    Professor at City of Hope National Medical Center
    Director of Cancer Immunotherapy Project

  • Dr. LEMING SHI

    Principal Investigator at FDA Toxicology Research Center
    Professor at Fudan University

  • Dr. JINWEI LOU

    Chairman of the Board
    Executive Director at Zhangjiang Translational Medical Research and Development Center
    Post-Doctorate at City of Hope National Medical Center
    Awarded Distinguished Expert for the Shanghai “Pujiang Talent”

  • Dr. CHENG XU

    Vice President, R&D
    Post-Doctorate at Stanford University, Princeton University Consultant at California Pacific Medical Center Awarded “National Distinguished Expert” for the “Pujiang Talent” and “Zhangjiang Outstanding Talent”

  • Dr. LING LIN

    General manager of medical big data division
    Doctor of Chinese Academy of Medical Sciences

  • Dr. SHOUXIN WU

    Fudan University
    Director of Medical Department
    Deputy Secretary of Zhongguancun  Strategic Alliance of Innovative Technology for Pancreatic Disease

Certification
  • Contact Us
  • Shanghai Biotecan Pharmaceuticals Co., Ltd.
  • Telephone:+86-21-50277725
  • Address

    First Shanghai Centre, 180 Zhangheng Rd., Pudong New District, Shanghai, China

Copyright © 2015-2018 Shanghai Biotecan Pharmaceuticals Co., Ltd. All Rights Reserved 沪ICP备09055310号-1 沪公网安备 31011502003232号